Youn H Kim

Dermatologic oncologist, Cutaneous oncology specialist, Dermatologist

The Joanne and Peter Haas, Jr., Professor for Cutaneous Lymphoma Research and Professor, by courtesy, of Medicine (Oncology) at the Stanford University Medical Center

Lymphoma Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Skin Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Residency: Stanford University School of Medicine (1989) CA

Board Certification: Dermatology, American Board of Dermatology (1989)

Internship: Kaiser - San Francisco (1985)

Medical Education: Stanford University School of Medicine (1984) CA

Doctor of Medicine, Stanford University, Medicine (1984)

Bachelor of Arts, Wellesley College, Chemistry (1980)

Honors & Awards

Alwin C. Rambar-James B.D. Mark Award for Excellence in Patient Care, Stanford University School of Medicine (2001)

Distinguished Service Award, Department of Dermatology, Stanford University School of Medicine (1995)

The Best Doctors in America: Pacific Region, Woodward/White, Inc (1996-)

Administrative Appointments

Director, Multi-disciplinary Cutaneous Lymphoma Program, Stanford University Medical Center (2004 - Present)

Director, Residency Program, Department of Dermatology, Stanford University Medical Center (2004 - Present)

Medical Director, Photopheresis Unit, Stanford University Medical Center (2004 - Present)

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Topical Chemotherapy in Cutaneous T-cell Lymphoma Positive Results of a Randomized, Controlled, Multicenter Trial Testing the Efficacy and Safety of a Novel Mechlorethamine, 0.02%, Gel in Mycosis Fungoides
Lessin, S. R., Duvic, M., Guitart, J., Pandya, A. G., Strober, B. E., & Kim, Y. H. (2013). Topical Chemotherapy in Cutaneous T-cell Lymphoma Positive Results of a Randomized, Controlled, Multicenter Trial Testing the Efficacy and Safety of a Novel Mechlorethamine, 0.02%, Gel in Mycosis Fungoides. JAMA DERMATOLOGY, 149(1), 25-32.

Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts
Lee, C. S., Ungewickell, A., Bhaduri, A., Qu, K., Webster, D. E., & Khavari, P. A. (2012). Transcriptome sequencing in Sezary syndrome identifies Sezary cell and mycosis fungoides-associated lncRNAs and novel transcripts. BLOOD, 120(16), 3288-3297.

Romidepsin Is Effective in Subcutaneous Panniculitis-Like T-Cell Lymphoma
Bashey, S., Krathen, M., Abdulla, F., Sundram, U., & Kim, Y. H. (2012). Romidepsin Is Effective in Subcutaneous Panniculitis-Like T-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 30(24), E221-E225.

Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma
Horwitz, S. M., Kim, Y. H., Foss, F., Zain, J. M., Myskowski, P. L., & Duvic, M. (2012). Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. BLOOD, 119(18), 4115-4122.

In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Kim, Y. H., Gratzinger, D., Harrison, C., Brody, J. D., Czerwinski, D. K., & Levy, R. (2012). In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study. BLOOD, 119(2), 355-363.

REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES
Harrison, C., Young, J., Navi, D., Riaz, N., Lingala, B., & Hoppe, R. (2011). REVISITING LOW-DOSE TOTAL SKIN ELECTRON BEAM THERAPY IN MYCOSIS FUNGOIDES. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 81(4), E651-E657.

Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma
Whittaker, S. J., Demierre, M.-F., Kim, E. J., Rook, A. H., Lerner, A., & Kim, Y. H. (2010). Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 28(29), 4485-4491.

In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study
Brody, J. D., Ai, W. Z., Czerwinski, D. K., Torchia, J. A., Levy, M., & Levy, R. (2010). In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study. JOURNAL OF CLINICAL ONCOLOGY, 28(28), 4324-4332.

Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome
Woo, D. K., Jones, C. R., Vanoli-Storz, M. N., Kohler, S., Reddy, S., & Kim, Y. H. (2009). Prognostic Factors in Primary Cutaneous Anaplastic Large Cell Lymphoma Characterization of Clinical Subset With Worse Outcome. ARCHIVES OF DERMATOLOGY, 145(6), 667-674.

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)
Kim, Y. H., Willemze, R., Pimpinelli, N., Whittaker, S., Olsens, E. A., & Hoppe, R. T. (2007). TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC). BLOOD, 110(2), 479-484.

Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma
Kim, Y. H., Duvic, M., Obitz, E., Gniadecki, R., Iversen, L., & Knox, S. J. (2007). Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma. BLOOD, 109(11), 4655-4662.

Multicenter Case Series of Indolent Small/Medium-Sized CD8(+) Lymphoid Proliferations With Predilection for the Ear and Face
Li, J. Y., Guitart, J., Pulitzer, M. P., Subtil, A., Sundram, U., & Querfeld, C. (2014). Multicenter Case Series of Indolent Small/Medium-Sized CD8(+) Lymphoid Proliferations With Predilection for the Ear and Face. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 36(5), 402-408.

Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome.
Querfeld, C., Rosen, S. T., Guitart, J., Duvic, M., Kim, Y. H., & Kuzel, T. M. (2014). Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sézary syndrome. Blood, 123(8), 1159-1166.

Intravascular ALK-negative Anaplastic Large Cell Lymphoma With Localized Cutaneous Involvement and an Indolent Clinical Course Toward Recognition of a Distinct Clinicopathologic Entity
Metcalf, R. A., Bashey, S., Wysong, A., Kim, J., Kim, Y. H., & Gratzinger, D. (2013). Intravascular ALK-negative Anaplastic Large Cell Lymphoma With Localized Cutaneous Involvement and an Indolent Clinical Course Toward Recognition of a Distinct Clinicopathologic Entity. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 37(4), 617-623.

Clonal Identity and Differences in Primary Cutaneous B-Cell Lymphoma Occurring at Different Sites or Time Points in the Same Patient
Fujiwara, M., Morales, A. V., Seo, K., Kim, Y. H., Arber, D. A., & Sundram, U. N. (2013). Clonal Identity and Differences in Primary Cutaneous B-Cell Lymphoma Occurring at Different Sites or Time Points in the Same Patient. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 35(1), 11-18.

Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin
Kim, Y. H., Demierre, M.-F., Kim, E. J., Lerner, A., Rook, A. H., & Whittaker, S. (2013). Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin. LEUKEMIA & LYMPHOMA, 54(2), 284-289.

Cutaneous gamma delta T-cell Lymphomas A Spectrum of Presentations With Overlap With Other Cytotoxic Lymphomas
Guitart, J., Weisenburger, D. D., Subtil, A., Kim, E., Wood, G., & Kim, Y. H. (2012). Cutaneous gamma delta T-cell Lymphomas A Spectrum of Presentations With Overlap With Other Cytotoxic Lymphomas. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 36(11), 1656-1665.

Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations
Mehta, N., Wayne, A. S., Kim, Y. H., Hale, G. A., Alvarado, C. S., & Horwitz, S. (2012). Bexarotene Is Active Against Subcutaneous Panniculitis-Like T-Cell Lymphoma in Adult and Pediatric Populations. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 12(1), 20-25.

A Comparative Analysis of Cutaneous Marginal Zone Lymphoma and Cutaneous Chronic Lymphocytic Leukemia
Levin, C., Mirzamani, N., Zwerner, J., Kim, Y., Schwartz, E. J., & Sundram, U. (2012). A Comparative Analysis of Cutaneous Marginal Zone Lymphoma and Cutaneous Chronic Lymphocytic Leukemia. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 34(1), 18-23.

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma
Kempf, W., Pfaltz, K., Vermeer, M. H., Cozzio, A., Ortiz-Romero, P. L., & Willemze, R. (2011). EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. BLOOD, 118(15), 4024-4035.

The frequency of dual TCR-PCR clonality in granulomatous disorders
Dabiri, S., Morales, A., Ma, L., Sundram, U., Kim, Y. H., & Kim, J. (2011). The frequency of dual TCR-PCR clonality in granulomatous disorders. JOURNAL OF CUTANEOUS PATHOLOGY, 38(9), 704-709.

Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma
Querfeld, C., Kuzel, T. M., Kim, Y. H., Porcu, P., Duvic, M., & Rosen, S. T. (2011). Multicenter phase II trial of enzastaurin in patients with relapsed or refractory advanced cutaneous T-cell lymphoma. LEUKEMIA & LYMPHOMA, 52(8), 1474-1480.

Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., & Vonderheid, E. C. (2011). Clinical End Points and Response Criteria in Mycosis Fungoides and Sezary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. JOURNAL OF CLINICAL ONCOLOGY, 29(18), 2598-2607.

The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides
Navi, D., Riaz, N., Levin, Y. S., Sullivan, N. C., Kim, Y. H., & Hoppe, R. T. (2011). The Stanford University Experience With Conventional-Dose, Total Skin Electron-Beam Therapy in the Treatment of Generalized Patch or Plaque (T2) and Tumor (T3) Mycosis Fungoides. ARCHIVES OF DERMATOLOGY, 147(5), 561-567.

Sezary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)
Olsen, E. A., Rook, A. H., Zic, J., Kim, Y., Porcu, P., & Duvic, M. (2011). Sezary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC). JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 64(2), 352-404.

Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Kim, Y. H., Girardi, M., Duvic, M., Kuzel, T., Link, B. K., & Rook, A. H. (2010). Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 63(6), 975-983.

Combined Use of PCR-Based TCRG and TCRB Clonality Tests on Paraffin-Embedded Skin Tissue in the Differential Diagnosis of Mycosis Fungoides and Inflammatory Dermatoses
Zhang, B., Beck, A. H., Taube, J. M., Kohler, S., Seo, K., & Zehnder, J. L. (2010). Combined Use of PCR-Based TCRG and TCRB Clonality Tests on Paraffin-Embedded Skin Tissue in the Differential Diagnosis of Mycosis Fungoides and Inflammatory Dermatoses. JOURNAL OF MOLECULAR DIAGNOSTICS, 12(3), 320-327.

A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders
Duvic, M., Reddy, S. A., Pinter-Brown, L., Korman, N. J., Zic, J., & Kim, Y. H. (2009). A Phase II Study of SGN-30 in Cutaneous Anaplastic Large Cell Lymphoma and Related Lymphoproliferative Disorders. CLINICAL CANCER RESEARCH, 15(19), 6217-6224.

Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells
Mattoch, I. W., Fulton, R., Kim, Y., Hoppe, R., Warnke, R. A., & Sundram, U. N. (2009). Cutaneous Peripheral T-Cell Lymphoma Associated With a Proliferation of B Cells. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 131(6), 810-819.

Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin
Weinberg, O. K., Ma, L., Seo, K., Beck, A. H., Pai, R. K., & Arber, D. A. (2009). Low Stage Follicular Lymphoma: Biologic and Clinical Characterization According to Nodal or Extranodal Primary Origin. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 33(4), 591-598.

Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab
Morales, A. V., Advani, R., Horwitz, S. M., Riaz, N., Reddy, S., & Kim, Y. H. (2008). Indolent primary cutaneous B-cell lymphoma: Experience using systemic rituximab. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(6), 953-957.

Cytologic Evaluation of Lymphadenopathy Associated With Mycosis Fungoides and Sezary Syndrome Role of Immunophenotypic and Molecular Ancillary Studies
Pai, R. K., Mullins, F. M., Kim, Y. H., & Kong, C. S. (2008). Cytologic Evaluation of Lymphadenopathy Associated With Mycosis Fungoides and Sezary Syndrome Role of Immunophenotypic and Molecular Ancillary Studies. CANCER CYTOPATHOLOGY, 114(5), 323-332.

Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease
Lee, J., Viakhireva, N., Cesca, C., Lee, P., Kohler, S., & Kim, Y. H. (2008). Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 59(4), 706-712.

Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates
Morales, A. V., Arber, D. A., Seo, K., Kohler, S., Kim, Y. H., & Sundram, U. N. (2008). Evaluation of B-cell clonality using the BIOMED-2 PCR method effectively distinguishes cutaneous B-cell lymphoma from benign lymphoid infiltrates. AMERICAN JOURNAL OF DERMATOPATHOLOGY, 30(5), 425-430.

European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas
Senff, N. J., Noordijk, E. M., Kim, Y. H., Bagot, M., Berti, E., & Willemze, R. (2008). European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. BLOOD, 112(5), 1600-1609.

Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma
Xie, X., Sundram, U., Natkunam, Y., Kohler, S., Hoppe, R. T., & Hsi, E. D. (2008). Expression of HGAL in primary cutaneous large B-cell lymphomas: evidence for germinal center derivation of primary cutaneous follicular lymphoma. MODERN PATHOLOGY, 21(6), 653-659.

Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.
Horwitz, S. M., Olsen, E. A., Duvic, M., Porcu, P., & Kim, Y. H. (2008). Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach. Journal of the National Comprehensive Cancer Network , 6(4), 436-442.

T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides
Thurber, S. E., Zhang, B., Kim, Y. H., Schrijver, I., Zehnder, J., & Kohler, S. (2007). T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 57(5), 782-790.

Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)
Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., & Whittaker, S. (2007). Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). BLOOD, 110(6), 1713-1722.

Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis
Richmond, H., Zwerner, J., Kim, Y., & Fiorentino, D. (2007). Nephrogenic systemic fibrosis - Relationship to gadolinium and response to photopheresis. ARCHIVES OF DERMATOLOGY, 143(8), 1025-1030.

Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma
Olsen, E. A., Kim, Y. H., Kuzel, T. M., Pacheco, T. R., Foss, F. M., & Duvic, M. (2007). Phase IIB multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 25(21), 3109-3115.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts
Huang, K. P., Weinstock, M. A., Clarke, C. A., McMillan, A., Hoppe, R. T., & Kim, Y. H. (2007). Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome - Evidence from population-based and clinical cohorts. ARCHIVES OF DERMATOLOGY, 143(1), 45-50.

Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology
Jayaraman, A. G., Cassarino, D., Advani, R., Kim, Y. H., Tsai, E., & Kohler, S. (2006). Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. JOURNAL OF CUTANEOUS PATHOLOGY, 33, 6-11.

Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography
Tsai, E. Y., Taur, A., Espinosa, L., Quon, A., Johnson, D., & Kim, Y. H. (2006). Staging accuracy in mycosis fungoides and Sezary syndrome using integrated positron emission tomography and computed tomography. ARCHIVES OF DERMATOLOGY, 142(5), 577-584.

Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study
Sundram, U., Kim, Y., Mraz-Gernhard, S., Hoppe, R., Natkunam, Y., & Kohler, S. (2005). Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study. JOURNAL OF CUTANEOUS PATHOLOGY, 32(3), 227-234.

Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients
Beynet, D. P., Wee, S. A., Horwitz, S. S., Kohler, S., Horning, S., & Kim, Y. H. (2004). Clinical and pathological features of posttransplantation lymphoproliferative disorders presenting with skin involvement in 4 patients. ARCHIVES OF DERMATOLOGY, 140(9), 1140-1146.

CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma
Liu, H. L., Hoppe, R. T., Kohler, S., Harvell, J. D., Reddy, S., & Kim, Y. H. (2003). CD30(+) cutaneous lymphoproliferative disorders: The Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 49(6), 1049-1058.

Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003). Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome - Clinical prognostic factors and risk for disease progression. ARCHIVES OF DERMATOLOGY, 139(7), 857-866.

Gene expression profiles of cutaneous B cell lymphoma
Storz, M. N., van de Rijn, M., Kim, Y. H., Mraz-Gernhard, S., Hoppe, R. T., & Kohler, S. (2003). Gene expression profiles of cutaneous B cell lymphoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 120(5), 865-870.

Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience
Kim, Y. H., Martinez, G., Varghese, A., & Hoppe, R. T. (2003). Topical nitrogen mustard in the management of mycosis fungoides - Update of the Stanford experience. ARCHIVES OF DERMATOLOGY, 139(2), 165-173.

Management with topical nitrogen mustard in mycosis fungoides.
Kim, Y. H. (2003). Management with topical nitrogen mustard in mycosis fungoides. Dermatologic therapy, 16(4), 288-298.

Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK (R))
Duvic, M., Kuzel, T., Olsen, E. A., Martin, A. G., Foss, F. M., & Liepa, A. (2002). Quality-of-life improvements in cutaneous T-cell lymphoma patients treated with denileukin diftitox (ONTAK (R)). CLINICAL LYMPHOMA, 2(4), 222-228.

Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea
Su, L. D., Kim, Y. H., LeBoit, P. E., Swetter, S. M., & Kohler, S. (2002). Interstitial mycosis fungoides, a variant of mycosis fungoides resembling granuloma annulare and inflammatory morphea. JOURNAL OF CUTANEOUS PATHOLOGY, 29(3), 135-141.

Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases
Harvell, J. D., Vaseghi, M., Natkunam, Y., Kohler, S., & Kim, Y. (2002). Large atypical cells of lymphomatoid papulosis are CD56-negative: a study of 18 cases. JOURNAL OF CUTANEOUS PATHOLOGY, 29(2), 88-92.

Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course
Mraz-Gernhard, S., Natkunam, Y., Hoppe, R. T., Leboit, P., Kohler, S., & Kim, Y. H. (2001). Natural killer/natural killer-like T-Cell lymphoma, CD56+, presenting in the skin: An increasingly recognized entity with an aggressive course. JOURNAL OF CLINICAL ONCOLOGY, 19(8), 2179-2188.

Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides
de Coninck, E. C., Kim, Y. H., Varghese, A., & Hoppe, R. T. (2001). Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides. JOURNAL OF CLINICAL ONCOLOGY, 19(3), 779-784.

Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., & Nichols, J. (2001). Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma. JOURNAL OF CLINICAL ONCOLOGY, 19(2), 376-388.

Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases
Natkunam, Y., Warnke, R. A., Haghighi, B., Su, L. D., Le Boit, P. E., & Kohler, S. (2000). Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases. JOURNAL OF CUTANEOUS PATHOLOGY, 27(8), 392-399.

Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides
Chui, C. T., Hoppe, R. T., Kohler, S., & Kim, Y. H. (1999). Epidermotropic cutaneous B-cell lymphoma mimicking mycosis fungoides. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 41(2), 271-274.

Mycosis fungoides and the Sezary syndrome
Kim, Y. H., & Hoppe, R. T. (1999). Mycosis fungoides and the Sezary syndrome. SEMINARS IN ONCOLOGY, 26(3), 276-289.

Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides
Chinn, D. M., Chow, S., Kim, Y. H., & Hoppe, R. T. (1999). Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 43(5), 951-958.

Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides
Kim, Y. H., Chow, S., Varghese, A., & Hoppe, R. T. (1999). Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. ARCHIVES OF DERMATOLOGY, 135(1), 26-32.

Role of histology in providing prognostic information in mycosis fungoides
SMOLLER, B. R., Detwiler, S. P., Kohler, S., Hoppe, R. T., & Kim, Y. H. (1998). Role of histology in providing prognostic information in mycosis fungoides. JOURNAL OF CUTANEOUS PATHOLOGY, 25(6), 311-315.

Mycosis fungoides in young patients: Clinical characteristics and outcome
Crowley, J. J., Nikko, A., Varghese, A., Hoppe, R. T., & Kim, Y. H. (1998). Mycosis fungoides in young patients: Clinical characteristics and outcome. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 38(5), 696-701.

Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sezary syndrome: A critical reappraisal
Kohler, S., Kim, Y. H., & SMOLLER, B. R. (1997). Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sezary syndrome: A critical reappraisal. JOURNAL OF CUTANEOUS PATHOLOGY, 24(5), 292-297.

Blastomycosis-like pyoderma in a man with AIDS
Crowley, J. J., & Kim, Y. H. (1997). Blastomycosis-like pyoderma in a man with AIDS. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 36(4), 633-634.

Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis
Kim, Y. H., Jensen, R. A., WATANABE, G. L., Varghese, A., & Hoppe, R. T. (1996). Clinical stage IA (limited patch and plaque) mycosis fungoides - A long-term outcome analysis. ARCHIVES OF DERMATOLOGY, 132(11), 1309-1313.

Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma
Wood, G. S., Salvekar, A., Schaffer, J., CROOKS, C. F., HENGHOLD, W., & SMOLLER, B. R. (1996). Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 107(3), 301-307.

Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30(+) primary cutaneous lymphoproliferative disorders and Hodgkin's disease
Wood, G. S., Hardman, D. L., Boni, R., Dummer, R., Kim, Y. H., & Burg, G. (1996). Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30(+) primary cutaneous lymphoproliferative disorders and Hodgkin's disease. BLOOD, 88(5), 1765-1770.

REASSESSMENT OF HISTOLOGIC PARAMETERS IN THE DIAGNOSIS OF MYCOSIS-FUNGOIDES
SMOLLER, B. R., Bishop, K., Glusac, E., Kim, Y. H., & Hendrickson, M. (1995). REASSESSMENT OF HISTOLOGIC PARAMETERS IN THE DIAGNOSIS OF MYCOSIS-FUNGOIDES. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 19(12), 1423-1430.

CUTANEOUS GNATHOSTOMIASIS
Crowley, J. J., & Kim, Y. H. (1995). CUTANEOUS GNATHOSTOMIASIS. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 33(5), 825-828.

PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME
Kim, Y. H., Bishop, K., Varghese, A., & Hoppe, R. T. (1995). PROGNOSTIC FACTORS IN ERYTHRODERMIC MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME. ARCHIVES OF DERMATOLOGY, 131(9), 1003-1008.

LYMPHOCYTE ANTIGEN ABNORMALITIES IN INFLAMMATORY DERMATOSES
SMOLLER, B. R., Bishop, K., Glusac, E. J., Bhargava, V., Kim, Y. H., & Warnke, R. A. (1995). LYMPHOCYTE ANTIGEN ABNORMALITIES IN INFLAMMATORY DERMATOSES. APPLIED IMMUNOHISTOCHEMISTRY, 3(2), 127-131.

REASSESSMENT OF LYMPHOCYTE IMMUNOPHENOTYPING IN THE DIAGNOSIS OF PATCH AND PLAQUE STAGE LESIONS OF MYCOSIS-FUNGOIDES
SMOLLER, B. R., Bishop, K., Glusac, E. J., Kim, Y. H., Bhargava, V., & Warnke, R. A. (1995). REASSESSMENT OF LYMPHOCYTE IMMUNOPHENOTYPING IN THE DIAGNOSIS OF PATCH AND PLAQUE STAGE LESIONS OF MYCOSIS-FUNGOIDES. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 3(1), 32-36.

CONSTITUTIVE ACTIVATION OF THE COLLAGENASE PROMOTER IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA FIBROBLASTS - ROLE OF ENDOGENOUSLY ACTIVATED AP-1
Unemori, E. N., Mauch, C., Hoeffler, W., Kim, Y., Amento, E. P., & BAUER, E. A. (1994). CONSTITUTIVE ACTIVATION OF THE COLLAGENASE PROMOTER IN RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA FIBROBLASTS - ROLE OF ENDOGENOUSLY ACTIVATED AP-1. EXPERIMENTAL CELL RESEARCH, 211(2), 212-218.

Autoimmunity to anchoring fibrils.
Kim, Y. H., & Woodley, D. T. (1994). Autoimmunity to anchoring fibrils. Advances in dermatology, 9, 61-77.

A DOUBLE-BLIND COMPARISON OF ADHESIVE BANDAGES WITH THE USE OF UNIFORM SUCTION BLISTER WOUNDS
Woodley, D. T., & Kim, Y. H. (1992). A DOUBLE-BLIND COMPARISON OF ADHESIVE BANDAGES WITH THE USE OF UNIFORM SUCTION BLISTER WOUNDS. ARCHIVES OF DERMATOLOGY, 128(10), 1354-1357.

RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA PHENOTYPE IS PRESERVED IN XENOGRAFTS USING SCID MICE - DEVELOPMENT OF AN EXPERIMENTAL INVIVO MODEL
Kim, Y. H., Woodley, D. T., WYNN, K. C., GIOMI, W., & BAUER, E. A. (1992). RECESSIVE DYSTROPHIC EPIDERMOLYSIS-BULLOSA PHENOTYPE IS PRESERVED IN XENOGRAFTS USING SCID MICE - DEVELOPMENT OF AN EXPERIMENTAL INVIVO MODEL. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 98(2), 191-197.

H-1-NMR SPECTROSCOPY - AN APPROACH TO EVALUATION OF DISEASED SKIN INVIVO
Kim, Y. H., Orenberg, E. K., Faull, K. F., WADEJARDETZKY, N. G., & Jardetzky, O. (1989). H-1-NMR SPECTROSCOPY - AN APPROACH TO EVALUATION OF DISEASED SKIN INVIVO. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 92(2), 210-216.